Who owns Nautilus Biotechnology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NAUT from SEC Form 13F filings across 87 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 87 institutions disclosed 43.0M shares of Nautilus Biotechnology, Inc. worth $61.0M — about 33.8% of shares outstanding; the largest disclosed holder is PERCEPTIVE ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
87
13F holders
$61.0M
value, 2026 filers
33.8%
of shares outstanding (43.0M sh)
10
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of NAUT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 11.6M | $16.4M | 0.3% | 9.1% | -0.6% |
| 2 | Cercano Management LLC | 7.2M | $10.2M | 1.4% | 5.6% | 0.0% |
| 3 | BlackRock, Inc. | 3.1M | $4.4M | 0.0% | 2.5% | +16.3% |
| 4 | a16z Capital Management, L.L.C. | 2.7M | $3.8M | 0.0% | 2.1% | -70.7% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $3.6M | 0.0% | 2% | 0.0% |
| 6 | Comprehensive Financial Management LLC | 2.2M | $3.1M | 0.1% | 1.7% | 0.0% |
| 7 | ACADIAN ASSET MANAGEMENT LLC | 2.1M | $3.0M | 0.0% | 1.7% | +101.9% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 1.6M | $2.3M | 0.0% | 1.3% | +134.3% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $2.0M | 0.0% | 1.1% | +11.0% |
| 10 | JPMORGAN CHASE & CO | 977,310 | $1.3M | 0.0% | 0.8% | +59.1% |
| 11 | Clearstead Advisors, LLC | 892,789 | $1.3M | 0.0% | 0.7% | 0.0% |
| 12 | SENTINEL TRUST CO LBA | 850,000 | $1.2M | 0.1% | 0.7% | +13.3% |
| 13 | STATE STREET CORP | 571,008 | $810,831 | 0.0% | 0.4% | +2.1% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 411,632 | $584,517 | 0.0% | 0.3% | +16.6% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 399,760 | $567,659 | 0.0% | 0.3% | +18.4% |
| 16 | NORTHERN TRUST CORP | 398,943 | $566,500 | 0.0% | 0.3% | +4.6% |
| 17 | Russell Investments Group, Ltd. | 280,276 | $397,990 | 0.0% | 0.2% | +6949.2% |
| 18 | FMR LLC | 256,198 | $363,801 | 0.0% | 0.2% | +7050.4% |
| 19 | Corient Private Wealth LP | 252,150 | $358,053 | 0.0% | 0.2% | +53.0% |
| 20 | ADAR1 Capital Management, LLCNEW | 251,926 | $357,735 | 0.0% | 0.2% | new |
| 21 | HILLMAN CO | 200,000 | $284,000 | 0.1% | 0.2% | 0.0% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 159,883 | $227,034 | 0.0% | 0.1% | +29.3% |
| 23 | HRT FINANCIAL LP | 158,289 | $224,000 | 0.0% | 0.1% | -56.2% |
| 24 | XTX Topco LtdNEW | 154,291 | $219,093 | 0.0% | 0.1% | new |
| 25 | GOLDMAN SACHS GROUP INC | 149,569 | $212,388 | 0.0% | 0.1% | -40.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.